Cidara Therapeutics, Inc. (CDTX) Financials
CDTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 63.5 million | 55.4 million |
2023-06-30 | 68.0 million | 52.6 million |
2023-03-31 | 81.7 million | 54.9 million |
2022-12-31 | 47.6 million | 50.5 million |
CDTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -1.8 million | 796000 |
2023-06-30 | 2.7 million | 795000 |
2023-03-31 | -11.0 million | 640000 |
2022-12-31 | -21.0 million | 673000 |
CDTX Net Income
No data available :(
CDTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 48.7 million | - | 4.4 million |
2023-06-30 | 50.4 million | - | 4.5 million |
2023-03-31 | 48.0 million | - | 1.0 million |
2022-12-31 | 32.7 million | - | 1.3 million |
CDTX Shares Outstanding
CDTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 126000 | 17.3 million | 3.6 million | - |
2023-06-30 | 107000 | 17.1 million | 3.3 million | - |
2023-03-31 | 94000 | 18.7 million | 4.3 million | - |
2022-12-31 | 9000 | 20.1 million | 3.4 million | - |
CDTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 12.7 million | 387000 |
2023-06-30 | 7.6 million | 401000 |
2023-03-31 | 26.0 million | 320000 |
2022-12-31 | 10.2 million | 29000 |
CDTX
Price: $12.51
52 week price:
Earnings Per Share: -0.39 USD
P/E Ratio: -1.87
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 3.0 million
Ebitda: -12.1 millionMarket Capitalization: 66.2 million